While the INRG does not incorporate tumor markers (VMA, HVA, NSE, LDH, and Ferritin) into the risk factors [6,36,37], they are widely used as standard clinical evaluations for both non-HR and HR cases [38]. The gene discussed is ENO2; the disease is neoplasm.